COR (Cencora) Other Long Term Assets : $3,760 Mil (As of Jun. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Cencora Other Long Term Assets?

Cencora's other long-term assets for the quarter that ended in Jun. 2024 was $3,760 Mil.

Cencora's quarterly other long-term assets increased from Dec. 2023 ($3,677 Mil) to Mar. 2024 ($3,823 Mil) but then stayed the same from Mar. 2024 ($3,823 Mil) to Jun. 2024 ($3,760 Mil).

Cencora's annual other long-term assets declined from Sep. 2021 ($2,085 Mil) to Sep. 2022 ($1,999 Mil) but then increased from Sep. 2022 ($1,999 Mil) to Sep. 2023 ($3,619 Mil).

Cencora Other Long Term Assets Historical Data

The historical data trend for Cencora's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Other Long Term Assets Chart

Cencora Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Other Long Term Assets

Get a 7-Day Free Trial

269.07

1,141.49

2,084.78

1,999.23

3,618.85

Cencora Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long Term Assets	Get a 7-Day Free Trial															3,617.47	3,618.85	3,677.31	3,822.89	3,759.72

Cencora Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Cencora Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (NYSE:COR) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

0HF3:UK ABG:Germany ABG:Germany C1CO34:Brazil ABC:Austria

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Executives

Steven H Collis	officer: President & CEO	1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Silvana Battaglia	officer: Executive Vice President	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Walgreens Boots Alliance, Inc.	10 percent owner	108 WILMOT ROAD, DEERFIELD IL 60015
Gina Clark	officer: Executive Vice President	1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Dermot Mark Durcan	director
Robert P. Mauch	officer: Executive Vice President	1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Elizabeth S Campbell	officer: Executive Vice President	1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Leslie E Donato	officer: EVP & Chief Strategy Officer	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Lazarus Krikorian	officer: Senior Vice President	1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Werner Baumann	director	1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Lauren M Tyler	director	C/O ALLEGHANY CORPORATION, 1411 BROADWAY, 34TH FLOOR, NEW YORK NY 10018
Redonda Miller	director	303 WYMAN STREET, SUITE 300, WALTHAM MA 02451
Lorence H. Kim	director	C/O SERES HEALTH, INC., 161 FIRST STREET, CAMBRIDGE MA 02472
Walgreens Boots Alliance Holdings Llc	10 percent owner	108 WILMOT ROAD, DEERFIELD IL 60015
Lon R Greenberg	director	460 NORTH GULPH ROAD, KING OF PRUSSIA PA 19406